| Biochemical markers in Alzheimer’s disease A Rabbito, M Dulewicz, A Kulczyńska-Przybik, B Mroczko International journal of molecular sciences 21 (6), 1989, 2020 | 101 | 2020 |
| Neurogranin and VILIP-1 as molecular indicators of neurodegeneration in Alzheimer’s disease: A systematic review and meta-analysis M Dulewicz, A Kulczyńska-Przybik, B Mroczko International journal of molecular sciences 21 (21), 8335, 2020 | 23 | 2020 |
| Biomarkers for the diagnosis of Alzheimer’s disease in clinical practice: the role of CSF biomarkers during the evolution of diagnostic criteria M Dulewicz, A Kulczyńska-Przybik, P Mroczko, J Kornhuber, P Lewczuk, ... International journal of molecular sciences 23 (15), 8598, 2022 | 18 | 2022 |
| Fatty acid binding protein 3 (FABP3) and apolipoprotein E4 (ApoE4) as lipid metabolism-related biomarkers of Alzheimer’s disease M Dulewicz, A Kulczyńska-Przybik, A Słowik, R Borawska, B Mroczko Journal of Clinical Medicine 10 (14), 3009, 2021 | 13 | 2021 |
| Neurogranin and neuronal pentraxin receptor as synaptic dysfunction biomarkers in Alzheimer’s disease M Dulewicz, A Kulczyńska-Przybik, A Słowik, R Borawska, B Mroczko Journal of Clinical Medicine 10 (19), 4575, 2021 | 11 | 2021 |
| A disintegrin and metalloproteinase (ADAM) family: Their significance in malignant tumors of the central nervous system (CNS) M Łukaszewicz-Zając, M Dulewicz, B Mroczko International Journal of Molecular Sciences 22 (19), 10378, 2021 | 11 | 2021 |
| The clinical significance of cerebrospinal fluid reticulon 4 (RTN4) levels in the differential diagnosis of neurodegenerative diseases A Kulczyńska-Przybik, M Dulewicz, A Słowik, R Borawska, A Kułakowska, ... Journal of Clinical Medicine 10 (22), 5281, 2021 | 10 | 2021 |
| Eotaxins and their receptor as biomarkers of colorectal cancer M Zajkowska, A Kulczyńska-Przybik, M Dulewicz, K Safiejko, M Juchimiuk, ... Journal of clinical medicine 10 (12), 2675, 2021 | 8 | 2021 |
| The implication of reticulons (RTNs) in neurodegenerative diseases: From molecular mechanisms to potential diagnostic and therapeutic approaches A Kulczyńska-Przybik, P Mroczko, M Dulewicz, B Mroczko International Journal of Molecular Sciences 22 (9), 4630, 2021 | 8 | 2021 |
| The significance of selected CC motif chemokine ligands in colorectal cancer patients M Zajkowska, M Dulewicz, A Kulczyńska-Przybik, K Safiejko, M Juchimiuk, ... Journal of Clinical Medicine 11 (7), 1794, 2022 | 7 | 2022 |
| Tetramodal Chemical Imaging Delineates the Lipid–Amyloid Peptide Interplay at Single Plaques in Transgenic Alzheimer’s Disease Models J Ge, S Koutarapu, D Jha, M Dulewicz, H Zetterberg, K Blennow, ... Analytical Chemistry 95 (10), 4692-4702, 2023 | 6 | 2023 |
| Kulczy nska-Przybik, A.; Mroczko, B. Neurogranin and VILIP-1 as Molecular Indicators of Neurodegeneration in Alzheimer’s Disease: A Systematic Review and Meta-Analysis M Dulewicz Int. J. Mol. Sci 21, 8335, 2020 | 6 | 2020 |
| Association of serum brain-derived tau with clinical outcome and longitudinal change in patients with severe traumatic brain injury F Gonzalez-Ortiz, M Dulewicz, NJ Ashton, PR Kac, H Zetterberg, ... JAMA Network Open 6 (7), e2321554-e2321554, 2023 | 5 | 2023 |
| Evaluation of synaptic and axonal dysfunction biomarkers in Alzheimer’s disease and mild cognitive impairment based on CSF and bioinformatic analysis M Dulewicz, A Kulczyńska-Przybik, R Borawska, A Słowik, B Mroczko International Journal of Molecular Sciences 23 (18), 10867, 2022 | 5 | 2022 |
| The relationships between cerebrospinal fluid glial (CXCL12, CX3CL, YKL-40) and synaptic biomarkers (Ng, NPTXR) in early Alzheimer’s disease A Kulczyńska-Przybik, M Dulewicz, J Doroszkiewicz, R Borawska, ... International Journal of Molecular Sciences 24 (17), 13166, 2023 | 3 | 2023 |
| Potential Utility of Cerebrospinal Fluid Glycoprotein Nonmetastatic Melanoma Protein B as a Neuroinflammatory Diagnostic Biomarker in Mild Cognitive Impairment and Alzheimer’s … J Doroszkiewicz, A Kulczyńska-Przybik, M Dulewicz, R Borawska, ... Journal of Clinical Medicine 12 (14), 4689, 2023 | 3 | 2023 |
| The assessment of ubiquitin C‐terminal hydrolase‐1 (UCH‐L1) in patients with Alzheimer’s disease A Kulczynska‐Przybik, M Dulewicz, P Mroczko, R Borawska, ... Alzheimer's & Dementia 18, e062156, 2022 | 3 | 2022 |
| The cerebrospinal fluid interleukin 8 (IL‐8) concentration in Alzheimer’s disease (AD) J Doroszkiewicz, A Kulczynska‐Przybik, M Dulewicz, R Borawska, ... Alzheimer's & Dementia 17, e051317, 2021 | 3 | 2021 |
| The significance of the Calbindin‐D in Alzheimer’s disease B Mroczko, A Kulczynska‐Przybik, R Borawska, M Dulewicz, ... Alzheimer's & Dementia 19, e062132, 2023 | 2 | 2023 |
| Comparative Analysis of Neurodegeneration and Axonal Dysfunction Biomarkers in the Cerebrospinal Fluid of Patients with Multiple Sclerosis A Kulczyńska-Przybik, M Dulewicz, J Doroszkiewicz, R Borawska, ... Journal of Clinical Medicine 11 (14), 4122, 2022 | 2 | 2022 |
